LinkedIn Profile

Access Optovue historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:optovue 695066 Dec 3rd, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Dec 3rd, 2020 12:07PM Dec 3rd, 2020 12:07PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Dec 2nd, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Dec 2nd, 2020 02:28PM Dec 2nd, 2020 02:28PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Dec 1st, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Dec 1st, 2020 01:55PM Dec 1st, 2020 01:55PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 30th, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 29th, 2020 07:59PM Nov 30th, 2020 02:47PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 28th, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 28th, 2020 03:35PM Nov 28th, 2020 03:35PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 27th, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 27th, 2020 12:00PM Nov 27th, 2020 12:00PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 26th, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 26th, 2020 12:58PM Nov 26th, 2020 12:58PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 25th, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 25th, 2020 06:33PM Nov 25th, 2020 06:33PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 24th, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 24th, 2020 01:52PM Nov 24th, 2020 01:52PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services
private:optovue 695066 Nov 23rd, 2020 12:00AM Optovue 11K 121.00 Open Medical Device Nov 23rd, 2020 03:52PM Nov 23rd, 2020 03:52PM Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness. The Optovue team is composed of seasoned professionals experienced in design, development, production, marketing, and sales of ophthalmic devices. The company is assisted by a Scientific and Medical Advisory Board composed of leaders in advanced OCT technology and ocular disease treatment. It was Jay Wei’s vision in the clinical use of OCT technology that resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, the RTVue®. The ultra-high speed, high resolution SD-OCT provides advanced ocular imaging capabilities that offer physicians significant benefits in helping to diagnose and manage patients suffering from macular degeneration, diabetic retinopathy, glaucoma and other macular diseases, as well as anterior segment diseases. The company expands the frontiers of OCT innovation and ophthalmic medical diagnostic imaging to improve the lives of patients. To date, Optovue has received regulatory clearances for: • RTVue OCT - Oct. 2006 • iVue portable OCT - April 2010 • Avanti Widefield OCT - April 2012 • Total Corneal Power, Oct. 2011 • iCam digital fundus camera - Jan. 2013 • iFusion combination OCT and fundus camera - July 2013 • iScan, software-assisted OCT – Sept. 2014 • AngioVue Imaging System – February 2016 • AngioAnalytics – June 2018 Open retinal imaging & diagnostics, anterior segment imaging & diagnostics, glaucoma diagnostics, spectral Domain Optical Coherence Tomography, optical coherence tomography angiography, optical coherence tomography, Ophthalmology, Optometry Open 2800 Bayview Drive Fremont CA US 94538 Optovue Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.